A carregar...
Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
Dasatinib and other tyrosine kinase inhibitors are commonly utilized in the management of chronic myelogenous leukemia. Pulmonary hypertension is an important adverse event associated with dasatinib. Mechanisms for pulmonary hypertension include pulmonary endothelial injury, apoptosis, and increased...
Na minha lista:
| Publicado no: | Pulm Circ |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664660/ https://ncbi.nlm.nih.gov/pubmed/31274047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019865704 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|